Sector
PharmaceuticalsOpen
₹0.44Prev. Close
₹0.46Turnover(Lac.)
₹0.12Day's High
₹0.48Day's Low
₹0.4452 Week's High
₹052 Week's Low
₹0Book Value
₹-6.22Face Value
₹10Mkt Cap (₹ Cr.)
4.74P/E
5.33EPS
0.09Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Equity Capital | 98.66 | 98.66 | 98.66 | 98.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -161.02 | -133.26 | -126.04 | -66.03 |
Net Worth | -62.36 | -34.6 | -27.38 | 32.63 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Revenue | 0.42 | 2.64 | 23.96 | 38.93 |
yoy growth (%) | -84.03 | -88.96 | -38.44 | -73.66 |
Raw materials | -0.42 | -2.54 | -22.8 | -36.84 |
As % of sales | 99.89 | 96.03 | 95.16 | 94.63 |
Employee costs | -0.13 | -0.11 | -0.75 | -1.57 |
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Profit before tax | -27.75 | -7.21 | -60.01 | -9.09 |
Depreciation | -0.05 | -1.5 | -2.77 | -2.75 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -12.04 | -8.71 | -57.42 | -12.84 |
Other operating items |
| Y/e 31 Mar | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -84.03 | -88.96 | -38.44 | -73.66 |
Op profit growth | 343.53 | -89.01 | 373.82 | -81.71 |
EBIT growth | 294.57 | -88.26 | 733.07 | -89.36 |
Net profit growth | 284.66 | -87.97 | 559.82 | -89.09 |
| Particulars (Rupees in Crores.) | Mar-2016 | Mar-2015 |
|---|---|---|
Gross Sales | 0 | 0.42 |
Excise Duty | 0 | 0 |
Net Sales | 0 | 0.42 |
Other Operating Income | 0 | 0 |
Other Income | 0.93 | 0.81 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,744.85 | 132.89 | 4,18,647.96 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,001.1 | 76.85 | 1,59,310.35 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,478.5 | 25.66 | 1,19,409.63 | 1,438.15 | 0.88 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,137.55 | 58.21 | 1,06,184.18 | 485 | 0.89 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,413.35 | 51.49 | 99,569.64 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
KANTILAL MANGALCHAND HIRAN
Additional Director
DARIYADEVI KANTILAL HIRAN
Director
HIRACHAND NEMICHAND BAFNA
Director
NITINN SATYENDRA GUPTA
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Hiran Orgochem Ltd
Summary
Hiran Orgochem Ltd., the Mumbai based company, is into manufacture of bulk drugs like Ciprofloxacian, Hydrochloride -USP. The companys plant at Panoli has an installed capacity of 240000 KGS.
Read More
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
